X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10909) 10909
Newsletter (1686) 1686
Book Review (1539) 1539
Publication (865) 865
Book Chapter (56) 56
Dissertation (27) 27
Magazine Article (27) 27
Conference Proceeding (24) 24
Book / eBook (13) 13
Newspaper Article (4) 4
Trade Publication Article (2) 2
Data Set (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (9820) 9820
humans (6910) 6910
cytochrome p-450 (5040) 5040
pharmacology & pharmacy (4584) 4584
animals (4540) 4540
male (4063) 4063
cytochrome p-450 enzyme system - metabolism (3533) 3533
female (2656) 2656
metabolism (2626) 2626
toxicology (2410) 2410
cytochrome p450 (2326) 2326
rats (2319) 2319
physiological aspects (1812) 1812
research (1752) 1752
enzymes (1696) 1696
liver (1614) 1614
cytochrome p-450 enzyme system - genetics (1585) 1585
adult (1520) 1520
microsomes, liver - enzymology (1517) 1517
drug interactions (1466) 1466
cytochrome p-450 cyp1a2 - metabolism (1460) 1460
pharmacokinetics (1443) 1443
analysis (1331) 1331
mice (1291) 1291
biochemistry & molecular biology (1280) 1280
in-vitro (1268) 1268
middle aged (1265) 1265
liver - enzymology (1219) 1219
expression (1137) 1137
induction (1119) 1119
microsomes, liver - metabolism (1091) 1091
liver - drug effects (1028) 1028
metabolites (1019) 1019
microsomes, liver - drug effects (1016) 1016
cytochrome p-450 cyp1a2 - genetics (930) 930
cytochrome p-450 enzyme inhibitors (910) 910
liver - metabolism (910) 910
cytochrome p-450 cyp1a1 - metabolism (903) 903
dose-response relationship, drug (886) 886
inhibition (874) 874
biotransformation (871) 871
cancer (851) 851
rats, sprague-dawley (849) 849
genotype (833) 833
kinetics (808) 808
human liver-microsomes (801) 801
aged (783) 783
cyp1a2 (780) 780
genetic aspects (767) 767
enzyme inhibitors - pharmacology (766) 766
reports (725) 725
cytochrome p-450 enzyme system - biosynthesis (697) 697
cytochrome p-450 cyp3a (696) 696
cytochrome p-450 cyp1a1 - genetics (694) 694
drugs (693) 693
hydroxylation (690) 690
gene expression (687) 687
isoenzymes - metabolism (684) 684
universities and colleges (674) 674
pharmacogenetics (654) 654
aryl hydrocarbon hydroxylases - metabolism (645) 645
cytochrome p-450 cyp1a2 (643) 643
oncology (639) 639
cells, cultured (624) 624
cytochrome (622) 622
rat (615) 615
pharmacology/toxicology (609) 609
cytochrome p-450 cyp3a - metabolism (604) 604
polymorphism, genetic (602) 602
enzyme induction - drug effects (573) 573
pharmacology (570) 570
toxicity (570) 570
enzyme induction (569) 569
drug metabolism (568) 568
drug-metabolism (564) 564
caffeine (548) 548
rna, messenger - metabolism (548) 548
rats, wistar (542) 542
gene-expression (533) 533
in vitro techniques (531) 531
chromatography, high pressure liquid (514) 514
microsomes (508) 508
aryl hydrocarbon hydroxylases - genetics (507) 507
substrate specificity (501) 501
genes (500) 500
proteins (499) 499
aryl hydrocarbon hydroxylases (494) 494
identification (483) 483
chemistry, medicinal (482) 482
article (481) 481
health aspects (480) 480
activation (478) 478
polymorphism (470) 470
genetic polymorphisms (465) 465
phenotype (465) 465
oxidation (451) 451
hepatocytes - drug effects (446) 446
mass spectrometry (444) 444
aryl-hydrocarbon receptor (433) 433
liver-microsomes (431) 431
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (12509) 12509
Chinese (65) 65
Russian (51) 51
Japanese (18) 18
German (11) 11
Polish (9) 9
French (8) 8
Spanish (8) 8
Dutch (2) 2
Italian (2) 2
Swedish (2) 2
Czech (1) 1
Danish (1) 1
Finnish (1) 1
Hungarian (1) 1
Norwegian (1) 1
Portuguese (1) 1
Slovak (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Drug Metabolism and Disposition, ISSN 0090-9556, 01/2010, Volume 38, Issue 1, pp. 92 - 99
The aim of the current study is to identify the human cytochrome P450 (P450) isoforms involved in the two oxidative steps in the bioactivation of clopidogrel... 
MECHANISM-BASED INHIBITION | ANTIAGGREGATING ACTIVITY | POLYMORPHISMS | TICLOPIDINE | PHARMACOKINETICS | HEALTHY-SUBJECTS | PHARMACOLOGY & PHARMACY | PRASUGREL | PHARMACODYNAMICS | MONOCLONAL-ANTIBODIES | ATORVASTATIN | Microsomes - metabolism | Humans | Aryl Hydrocarbon Hydroxylases - genetics | Cytochrome P-450 Enzyme System - metabolism | Sulfaphenazole - pharmacology | Microsomes - drug effects | Cytochrome P-450 CYP3A - genetics | Cytochrome P-450 CYP1A2 - genetics | Antibodies - immunology | Omeprazole - pharmacology | Microsomes, Liver - enzymology | Platelet Aggregation Inhibitors - pharmacokinetics | Ticlopidine - pharmacokinetics | Oxidoreductases, N-Demethylating - metabolism | Aryl Hydrocarbon Hydroxylases - immunology | Oxidation-Reduction | Enzyme Inhibitors - pharmacology | Ticlopidine - analogs & derivatives | Oxidoreductases, N-Demethylating - immunology | Cytochrome P-450 CYP3A - metabolism | Cell Line, Tumor | Cytochrome P-450 Enzyme System - genetics | Theophylline - pharmacology | Kinetics | Cytochrome P-450 CYP2C9 | Theophylline - analogs & derivatives | Oxidoreductases, N-Demethylating - genetics | Glutathione - metabolism | Ketoconazole - pharmacology | Biotransformation - physiology | Cytochrome P-450 CYP1A2 Inhibitors | Microsomes, Liver - drug effects | Ticlopidine - metabolism | NADP - metabolism | Platelet Aggregation Inhibitors - metabolism | Cytochrome P-450 CYP3A - immunology | Cell Line | Aryl Hydrocarbon Hydroxylases - antagonists & inhibitors | Cytochrome P-450 CYP1A2 - immunology | Biocatalysis | Mephenytoin - analogs & derivatives | Cytochrome P-450 CYP1A2 - metabolism | Aryl Hydrocarbon Hydroxylases - metabolism | Mephenytoin - pharmacology | Antibodies - pharmacology | Cytochrome P-450 CYP3A Inhibitors | Cytochrome P-450 CYP2C19 | Clopidogrel | Cytochrome P-450 CYP2B6 | Index Medicus
Journal Article
Drug Metabolism and Disposition, ISSN 0090-9556, 08/2016, Volume 44, Issue 8, pp. 1217 - 1228
Journal Article
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 08/2017, Volume 60, Issue 15, pp. 6678 - 6692
Porcupine is an O-acyltransferase that regulates Wnt secretion. Inhibiting porcupine may block the Wnt pathway which is often dysregulated in various cancers.... 
TARGET | CHEMISTRY, MEDICINAL | PATHWAY | MECHANISMS | BETA-CATENIN | WNT | CANCER | Acyltransferases - antagonists & inhibitors | Maleimides - administration & dosage | Cytochrome P-450 CYP3A Inhibitors - pharmacology | Antineoplastic Agents - chemical synthesis | Humans | Microsomes, Liver - metabolism | Maleimides - pharmacology | Cytochrome P-450 CYP3A Inhibitors - pharmacokinetics | Structure-Activity Relationship | Antineoplastic Agents - administration & dosage | Pyridazines - pharmacology | Pyridazines - chemical synthesis | Maleimides - pharmacokinetics | Cytochrome P-450 CYP1A2 Inhibitors - pharmacokinetics | Maleimides - chemical synthesis | HEK293 Cells | Pyridazines - administration & dosage | Female | Antineoplastic Agents - pharmacokinetics | Antineoplastic Agents - pharmacology | Cytochrome P-450 CYP2D6 Inhibitors - pharmacology | Wnt Signaling Pathway | Cytochrome P-450 CYP2D6 Inhibitors - pharmacokinetics | Cytochrome P-450 CYP3A Inhibitors - administration & dosage | Rats | Cytochrome P-450 CYP1A2 Inhibitors - chemical synthesis | Cytochrome P-450 CYP2D6 Inhibitors - administration & dosage | Cytochrome P-450 CYP3A Inhibitors - chemical synthesis | Xenograft Model Antitumor Assays | Animals | Cytochrome P-450 CYP1A2 Inhibitors - pharmacology | Cytochrome P-450 CYP2D6 Inhibitors - chemical synthesis | High-Throughput Screening Assays | Membrane Proteins - antagonists & inhibitors | Mice, Nude | Cytochrome P-450 CYP1A2 Inhibitors - administration & dosage | Cell Line, Tumor | Pyridazines - pharmacokinetics | Mice, Inbred BALB C | Index Medicus
Journal Article
Molecular and Cellular Biochemistry, ISSN 0300-8177, 6/2014, Volume 391, Issue 1, pp. 127 - 136
Incense smoke is increasingly being recognized as a potential environmental contaminant and is linked to malignant and non-malignant respiratory diseases. The... 
Life Sciences | Biochemistry, general | Cytochrome p-450 | Oxidative stress | Lung | Liver | Incense | Medical Biochemistry | Oncology | Inflammation | Cardiology | PARTICLES | POLYCYCLIC AROMATIC-HYDROCARBONS | RISK | DNA ADDUCT FORMATION | CELL BIOLOGY | HEPATOCELLULAR-CARCINOMA | ORGANIC EXTRACTS | CIGARETTE-SMOKE | AIR-POLLUTANTS | EXPRESSION | PARTICULATE MATTER | Tumor Necrosis Factor-alpha - metabolism | Cytochrome P-450 CYP1A1 - genetics | Cytochrome P-450 CYP1B1 - genetics | Inflammation - pathology | Liver - pathology | Liver - enzymology | Rats, Wistar | Cytochrome P-450 CYP1B1 - metabolism | Male | RNA, Messenger - metabolism | Cytochrome P-450 CYP1B1 - biosynthesis | Lung - enzymology | Organ Specificity - genetics | Cytochrome P-450 CYP1A2 - genetics | Biomarkers - metabolism | Lung - pathology | Smoke - adverse effects | Interleukin-4 - metabolism | RNA, Messenger - genetics | Oxidative Stress - genetics | Enzyme Induction | Cytochrome P-450 CYP1A1 - metabolism | Cytochrome P-450 CYP1A2 - metabolism | Environmental Exposure - adverse effects | Animals | Cytochrome P-450 CYP1A2 - biosynthesis | Perfume - adverse effects | Cytochrome P-450 CYP1A1 - biosynthesis | Inflammation - enzymology | Metabolites | Polycyclic aromatic hydrocarbons | DNA | Cytochrome P-450 | Enzymes | Biochemistry | DNA damage | Index Medicus
Journal Article
International Journal of Nanomedicine, ISSN 1176-9114, 2018, Volume 13, pp. 8561 - 8575
Introduction and objective: Currently, carbon nanostructures are vastly explored materials with potential for future employment in biomedicine. The possibility... 
Nanoparticles | Carbon nanostructures | Cytochrome p450 | Liver | Microsomes | liver | POLYCYCLIC AROMATIC-HYDROCARBONS | NANOMATERIALS | NANOSCIENCE & NANOTECHNOLOGY | TOXICITY | carbon nanostructures | cytochrome P450 | INDUCTION | DRUG-METABOLIZING-ENZYMES | WALLED CARBON NANOTUBES | nanoparticles | HEPG2 CELLS | PHARMACOLOGY & PHARMACY | EXPRESSION | CYTOCHROME-P450 ENZYME | microsomes | Cytochrome P-450 CYP2D6 - genetics | Nanostructures - ultrastructure | Cytochrome P-450 Enzyme Inhibitors | Cell Survival | Humans | Liver - metabolism | Cytochrome P-450 Enzyme System - metabolism | Fluorescence | Hydrodynamics | Hepatocytes - metabolism | Diamond - chemistry | Cytochrome P-450 CYP1A2 - metabolism | Down-Regulation - genetics | Hep G2 Cells | Cytochrome P-450 CYP3A - genetics | Cytochrome P-450 CYP3A - metabolism | Isoenzymes - metabolism | Cytochrome P-450 CYP1A2 - genetics | Cytochrome P-450 CYP2D6 - metabolism | Cytochrome P-450 Enzyme System - genetics | Nanostructures - chemistry | Graphite - chemistry | Cytochrome P-450 Enzyme System - pharmacology | Hepatocytes - drug effects | Diamond crystals | RNA | Isoenzymes | Graphene | Genes | Cytochrome P-450 | Diamonds | Graphite | Genetic research | Genetic aspects | Gene expression | Cytochrome | Enzymes | Drug delivery systems | Nanomaterials | Metabolism | Carbon | Drug dosages | Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2015, Volume 10, Issue 7, pp. e0132992 - e0132992
Human pluripotent stem cell-derived hepatocytes have the potential to provide in vitro model systems for drug discovery and hepatotoxicity testing. However,... 
DNA METHYLATION | HUMAN LUNG | QUANTIFICATION | MULTIDISCIPLINARY SCIENCES | PLACENTA | HUMAN LIVER | HUMAN CYP1A1 | MECHANISMS | CYP2E1 | DIFFERENTIATION | EXPRESSION | Chromatin - metabolism | Cytochrome P-450 CYP1A1 - genetics | Cytochrome P-450 CYP1B1 - genetics | Epigenesis, Genetic | Human Embryonic Stem Cells - cytology | Humans | Cytochrome P-450 CYP1B1 - metabolism | Cytochrome P-450 CYP2E1 - genetics | Cytochrome P-450 CYP2E1 - metabolism | Hepatocytes - metabolism | DNA Methylation | Hepatocytes - cytology | Cytochrome P-450 CYP1A2 - genetics | Transcription, Genetic | Cell Differentiation | Chromatin - ultrastructure | Cell Line | Cytochrome P-450 CYP2D6 - genetics | Human Embryonic Stem Cells - metabolism | DNA Modification Methylases - metabolism | Histone Deacetylases - genetics | Signal Transduction | Histone Deacetylases - metabolism | Cytochrome P-450 CYP1A1 - metabolism | Organ Specificity | Cytochrome P-450 CYP1A2 - metabolism | DNA Modification Methylases - genetics | Histones - genetics | CpG Islands | Cytochrome P-450 CYP2D6 - metabolism | Protein Processing, Post-Translational | Histones - metabolism | Primary Cell Culture | Epigenetic inheritance | Methylation | Embryonic stem cells | Genes | Cytochrome P-450 | Cytochrome | Chromatin | Transcription | Toxicity | Gene regulation | Liver | Science | Demethylation | Rodents | Toxicity testing | DNA methylation | Inhibition | Hepatotoxicity | CYP2D6 protein | Deoxyribonucleic acid--DNA | CpG islands | Enzymes | Cytochrome P450 | CYP1A2 protein | Gene expression | Hepatocytes | Stem cells | Pluripotency | Combinatorial analysis | Index Medicus | Deoxyribonucleic acid | DNA
Journal Article
Journal Article
Journal Article
Journal Article
Life Sciences, ISSN 0024-3205, 12/2017, Volume 190, pp. 46 - 51
Journal Article
Drug metabolism and disposition: the biological fate of chemicals, ISSN 0090-9556, 2015, Volume 43, Issue 6, pp. 819 - 828
Journal Article